-
Are you performing unnecessary preoperative tests? If so, you're wasting expensive staff time required to conduct them and analyze them, as well as supplies needed to conduct them. In addition, you're experiencing potentially unnecessary surgical delays due to false positives.
-
A new tool that calculates the financial and environmental impact of reprocessing is available from Phoenix, AZ-based Ascent, a division of Stryker Corp.
-
Would you like to realize dramatic cost savings, including cutting your interest rates in half? Meet with your bank once a year, suggests Joan Shearer, CASC, administrator of Lawrence (KS) Surgery Center.
-
Two simple cost-effective methods communications team training and a surgical checklist have been shown in a study to reduce postoperative complications, which are the most expensive medical errors, averaging $14,500 per case.
-
-
At some point, after reducing cost so much, we are going to realize that the best option is to not do surgery at all. Think of the savings!
-
A new toolkit for healthcare professionals was created to enhance safety for patients who have obstructive sleep apnea and are undergoing outpatient surgery.
-
Gabapentin for Chronic Cough; Can Statins Reduce Cancer-Related Mortality?; Are All of Those Multivitamin Dollars Well Spent?
-
The FDA has approved the first in class α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor antagonist for the treatment of seizures. Perampanel is an orally active noncompetitive AMPA antagonist. The drug is marketed by Eisai Inc. as Fycompa.
-
The ECG shown above was obtained from a 74-year-old woman who presented with abrupt onset of severe renal colic but no chest pain.
